Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

NCT02674594 ·Status: COMPLETED

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial

NCT01288352 ·Status: COMPLETED ·Phase: PHASE4

Apixaban in Atrial Fibrillation Registry

NCT02563639 ·Status: COMPLETED

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

NCT04642430 ·Status: RECRUITING ·Phase: PHASE4

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

NCT01701817 ·Status: COMPLETED

Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI

NCT03656523 ·Status: COMPLETED

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

NCT05471830 ·Status: COMPLETED

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

NCT03311139 ·Status: COMPLETED

REVEAL AF: Incidence of AF in High Risk Patients

NCT01727297 ·Status: COMPLETED ·Phase: NA

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

NCT03508258 ·Status: WITHDRAWN

Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation

NCT02839304 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

NCT05471505 ·Status: COMPLETED

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

NCT02633982 ·Status: UNKNOWN

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures

NCT02274857 ·Status: COMPLETED ·Phase: NA

Electrophysiological Effects of NACOS and AVK on Pulmonary Veins and Left Atrium in Paroxysmal AF Catheter Ablation

NCT02814955 ·Status: UNKNOWN

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

NCT03702582 ·Status: COMPLETED ·Phase: PHASE3

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

NCT05027061 ·Status: COMPLETED

Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

NCT00911300 ·Status: COMPLETED ·Phase: PHASE2

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

NCT06949319 ·Status: RECRUITING

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

NCT02339493 ·Status: COMPLETED ·Phase: NA

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

NCT01706146 ·Status: COMPLETED ·Phase: PHASE4

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)

NCT00392054 ·Status: COMPLETED ·Phase: PHASE3

Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) Patients

NCT00703157 ·Status: TERMINATED ·Phase: NA

Atrial Fibrillation Research Database

NCT03760874 ·Status: UNKNOWN

Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation

NCT03002740 ·Status: WITHDRAWN